infigratinib 0.25 mg/kg/day clinical trials

An Interventional Study of Infigratinib in Children With Hypochondroplasia

This study is looking at a new medicine called infigratinib for children with hypochondroplasia (a type of short stature). It's checking if the medicine is safe and helps children grow better. Children aged 3 to 18 might be able to take part.